Heidi Overton faced a contentious Senate hearing Wednesday, where she declined to verify claims about drug costs and birth control during her nomination for FDA commissioner. The nominee broke with President Trump on the safety of the measles vaccine and failed to confirm the president's assertion that the U.S. pays the lowest prescription drug prices in the world when pressed by Senator Bernie Sanders.

Senator Patty Murray further questioned whether an intrauterine device (IUD) should be classified as an abortifacient, alleging that the previous administration had mislabeled birth control. Overton did not provide a direct answer to the query, stating she would be fully briefed on such matters if confirmed. The hearing focused on the nominee's willingness to maintain independent agency standards despite presidential pressure.